Getnet Yimer Selected Research

Getnet Yimer Research Topics

Disease

17	Tuberculosis (Tuberculoses) 10/2021 - 03/2008
6	Coinfection 01/2021 - 03/2008
5	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2019
4	Chemical and Drug Induced Liver Injury 01/2017 - 01/2011
3	Pulmonary Tuberculosis 10/2021 - 07/2014
3	Cough 10/2021 - 01/2021
3	Drug-Related Side Effects and Adverse Reactions 01/2021 - 01/2020
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2021 - 01/2019
2	Anemia 12/2020 - 01/2019
2	Asthma (Bronchial Asthma) 06/2020 - 01/2020
2	Vitamin D Deficiency 01/2019 - 08/2016
1	HIV Infections (HIV Infection) 10/2021
1	Pain (Aches) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Vomiting 01/2021
1	Stomatitis 01/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Constipation 01/2021
1	Dysgeusia (Parageusia) 01/2021
1	Dyspnea (Shortness of Breath) 01/2021
1	Hyperpigmentation 01/2021
1	Fatigue 01/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021
1	Leukopenia 12/2020
1	Gastroesophageal Reflux (GERD) 01/2020
1	Rhinosinusitis 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Obesity 01/2020
1	Ototoxicity 01/2019
1	Parasitemia 01/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Neutropenia 01/2019
1	Malaria 01/2019
1	Body Weight (Weight, Body) 01/2017
1	Colonic Neoplasms (Colon Cancer) 10/2015
1	Carcinogenesis 10/2015
1	Aberrant Crypt Foci 10/2015
1	Immune Reconstitution Inflammatory Syndrome 01/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2015
1	Infections 10/2012

Drug/Important Bio-Agent (IBA)

6	Rifampin (Rifampicin)FDA LinkGeneric 10/2021 - 01/2011
6	efavirenz (Sustiva)FDA Link 01/2021 - 01/2011
5	Pharmaceutical PreparationsIBA 10/2021 - 03/2008
4	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2011
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2020 - 01/2019
2	Vitamin D FDA LinkGeneric 01/2019 - 08/2016
2	Methanol (Carbinol)IBA 01/2019 - 10/2015
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2017 - 03/2014
2	Cytochrome P-450 CYP3AIBA 01/2017 - 08/2016
1	rifapentine (Priftin)FDA Link 10/2021
1	Isoniazid (Ftivazide)FDA LinkGeneric 10/2021
1	Levofloxacin (Levaquin)FDA Link 01/2021
1	Moxifloxacin (Avelox)FDA Link 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020
1	Alkaline PhosphataseIBA 12/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2020
1	AllergensIBA 06/2020
1	AnthracyclinesIBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	Tamoxifen FDA LinkGeneric 01/2019
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2019
1	SolventsIBA 01/2019
1	Chloroform (Trichloromethane)IBA 01/2019
1	Capreomycin (Capastat)FDA Link 01/2019
1	AminoglycosidesIBA 01/2019
1	Butanols (Butyl Alcohols)IBA 01/2019
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2017
1	HLA-B57 antigenIBA 01/2017
1	8-hydroxyefavirenzIBA 12/2016
1	Antitubercular AgentsIBA 09/2016
1	hydroxide ionIBA 08/2016
1	CholesterolIBA 08/2016
1	DimethylhydrazinesIBA 10/2015
1	Cyclooxygenase InhibitorsIBA 10/2015
1	RNA (Ribonucleic Acid)IBA 01/2015
1	Keratin-18 (Keratin 18)IBA 03/2014
1	ImmunosorbentsIBA 03/2014
1	Complement System Proteins (Complement)IBA 03/2014
1	EnzymesIBA 03/2014
1	Alanine Transaminase (SGPT)IBA 03/2014
1	IgG Receptors (Fc gamma RI)IBA 01/2013
1	DefensinsIBA 10/2012
1	Antiviral Agents (Antivirals)IBA 01/2011

Therapy/Procedure

11	Therapeutics 10/2021 - 03/2008
6	Drug Therapy (Chemotherapy) 01/2021 - 07/2014
6	Highly Active Antiretroviral Therapy (HAART) 01/2020 - 01/2013
1	Treatment Delay 10/2021
1	Critical Care (Surgical Intensive Care) 09/2020
1	Injections 01/2019
1	Traditional Medicine (Folk Remedies) 01/2019
1	Chemoprevention 10/2015
1	Art Therapy 07/2014